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Electrophysiological techniques are essential for the diagnosis of cystic fibrosis. In the past ten years intestinal current measurements has
emerged as valuable tool for this purpose. This overview highlights the objectives, methodology and current protocols to diagnose cystic
fibrosis by intestinal current measurement on rectal biopsies.
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clinical interpretation of the phenotypic features and further
confirmed by the well-established sweat test and mutational
analysis. However, an increasing number of patients does
neither carry any of the most common mutations in the
CFTR gene nor expose the classical clinical symptoms that
per se justify the diagnosis of CF. To supplement the
diagnostic criteria in these patients, the technique of intes-
tinal current measurements (ICM) can be a useful tool. ICM
is an ex-vivo method in which a freshly obtained rectal
biopsy is tested in an Ussing chamber for its electrical
response to a series of secretagogues. The discriminatory
feature between CF and non-CF individuals is the amount of
Cl secretion in response to agonists that increase intracel-
lular cAMP that is absent or subnormal in biopsies from
patients with CF. To this end, two different ICM protocols
are available which are described in more detail in two
subsequent articles [1,2].
Short-circuit current measurements on intestinal biopsies
date back to the early 1960s and have initially been used to
understand the properties of electrolyte transport in the
jejunum [3]. Some 20 years later, Berschneider et al. [4]
were among the first to utilize this technique in order to1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
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patients and non-CF individuals. In the early 1990s, the
CF research group at the Erasmus University in Rotterdam1
applied ICM to colonic biopsies of a wide array of patients
and recognised the value of this technique to confirm the
diagnosis of CF [5,6]. The protocol has meanwhile been
adopted by a number of labs worldwide and is based on the
following steps: A freshly obtained rectal suction biopsy is
mounted into a micro-Ussing chamber and then equilibrated
with carbogen-gassed glucose-containing Meyler’s buffer.
Experiments are performed in short-circuit mode in a
recirculating bath chamber. The tissue is then exposed to
the following sequence of drugs: (1) amiloride; (2) indo-
methacin; (3) carbachol; (4) cAMP/forskolin; (5) 4,4V-
diisothiocyanatostilbene-2,2V-disulfonic acid; and (6) hista-
mine. The responses to carbachol, cAMP/forskolin and
histamine given as change in short-circuit current (DISC)
are the means to differentiate between CF, CFTR-related
diseases and non-CF.
The protocol developed by the CF research group at the
University Hospital in Freiburg2 has a somewhat different
approach [7,8]. Measurements are performed under open-
circuit conditions using a novel perfused Ussing chamber that
allows the wash-out of substances applied to the apical ored by Elsevier B.V. All rights reserved.
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of buffer solution on both sides of the epithelium obliviates
the need for permanent oxygenation of the perfusate. The
biopsymaterial is exposed to a similar sequence of drugs as in
the Rotterdam protocol, hence the perfused mode of the setup
allows for repetitive stimulation with the same agonists under
different experimental conditions. Drugs are applied in the
following order: (1) amiloride; (2) carbachol; (3) indometh-
acin; (4) carbachol; (5) IBMX/forskolin; (6) carbachol; and
finally (7) bumetanide. The evaluation relies primarily on the
cAMP-mediated Cl secretion as measured by the change in
the transepithelial voltage difference (DVte). The respective
change in the equivalent ISC can be deduced from this value
using Ohm’s law. Additional information can be drawn from
the paired examination of secretion induced by cholinergic
stimulation in the absence (indomethacin) and presence of
(IBMX/forskolin-mediated) cAMP activation.
In both protocols, the CF state is recognised by insuffi-
cient Cl secretion after stimulation with agonists that act
either via intracellular cAMP or Ca2 +. Both the open- and
short-circuit modes of recording should in principle reveal
the same information about the responsiveness of the rectal
tissue to secretagogues. Under open-circuit conditions, no
extra ion flow is imposed upon the tissue, except during the
short-current pulse periods that are required to estimate
tissue resistance. Hence, under this experimental setup the
perturbation is kept to a minimum. On the other hand,
measurements under short-circuit conditions have the ad-
vantage to directly measure the charge flux across the tissue
at a given clamp voltage thus reporting the transport
capacity of the epithelium. Future control experiments in
which biopsies taken from the same individual at the same
time and run in parallel under both modes should resolve
whether either technique does have an advantage over the
other. However, according to the preliminary data gained by
the Hannover group, open-circuit voltage and ISC recordings
look virtually identical in their responses to the applied
drugs. Additional investigations that evaluate whether dif-
ferences in the experimental conditions and buffers used by
the two protocols might affect the response of the tissue
would benefit the discussion.
Clearly, endpoints that justify the diagnosis of CF must be
defined. Similar to the values for sweat Cl concentrationspublished in the widely accepted U.S. consensus document
[9], we will need to implement guidelines that contain the
corresponding values for DISc and DVte, respectively.
Time will tell which of the two protocols or modifica-
tions thereof are more appropriate to make a CF diagnosis in
cases of atypical clinical presentation with equivocal out-
come of CFTR mutation analysis and/or sweat testing. The
promising finding of an association of the amount and type
of Cl secretory residual response in CF patients with the
clinical course of the disease needs to be substantiated in a
larger cohort of patients. If confirmed, ICM can be
employed to make a diagnosis for atypical forms of CF
and to differentiate the severity of the basic defect in
classical CF.References
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